Learning Objectives:

  1. Understanding heterogeneity among MSI-H/MMR-D colorectal cancer patients
  2. Reviewing potential clinical and molecular biomarkers of response to immune checkpoint inhibitor in MSI-H/MMR-D patients
  3. Reviewing future therapeutic opportunities for MSI-H/MMR-D colorectal cancer patients
Session date: 
09/16/2019 - 12:00pm to 1:00pm CDT
900 East 57th Street
KCBD Auditorium 1103
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Ibrahim H. Sahin, MD